Biopharma Insights - page 4

This Company Claims World-First AI Models For Programmable Gene Insertion

That’s the headline from Basecamp Research this week, and if it holds up, it’s an important signal for genetic medicine field.

Continue ›››

Neurotech Trends in 2025: When Use Cases Started Driving Design

Neurotechnology development in 2025 showed a shift from exploratory demonstration toward systems engineered around specific clinical and research uses. Across brain–computer interfaces, neuromodulation, diagnostics, and experimental neuroscience, design choices increasingly …

Continue ›››

2025 Neurotech Review: BCIs, Brain Delivery, Organoids and Neuro-AI Move Closer to Clinic

Forward signals for 2026—from >$1.3B in tracked financings led by Neuralink’s $650M round to a shoebox-sized biocomputer, driven device control, speech restoration, and early clinical proof points. As we step …

Continue ›››

From Animals to Algorithms: How AI Brings Drug Testing Closer to Human Biology

Preclinical and nonclinical testing of drugs has traditionally relied on animal models to assess efficacy and toxicity before moving into human trials. However, these models raise ethical concerns and are …

Continue ›››

The Emergence of Diffusion Generative Models in Accelerating AI Drug Discovery

Recently, diffusion generative models, such as DALL-E 3, Midjourney or Imagen, have attracted considerable interest for their ability to create captivating and inventive images based on textual prompts. Researchers at …

Continue ›››

Beyond Traditional Medicine: Exploring the Revolutionary Therapies Transforming Patient Care

Biotechnology has revolutionized the healthcare industry, and with the increasing demand for advanced therapies, the focus has shifted towards innovative therapeutic modalities. In this blog article, we will explore some …

Continue ›››

10 Companies Shaping the Brain-Computer Interface Landscape: Invasive vs Non-Invasive BCI Technology

The brain–computer interface (BCI) technology domain is constantly progressing as researchers and companies collaborate to devise inventive solutions that connect the human brain with external devices. This expanding sector, driven …

Continue ›››

Aging, AI, and the Uneven Road to Longevity Medicine

Echoing notes from ARDD2025, we briefly overview geroscience, its fusion with AI, what companies pursue in this field and limitations on the way of longevity medicine. А couple of weeks …

Continue ›››

Unified Discovery: How ASCEND's Conversational AI Bridges Internal and Public Data for Accelerated Oncology Insights

Why European Life Science’s Momentum May Finally Become Unstoppable

Living in Europe and watching the scene firsthand, it seems biotech here doesn’t revolve around a single gravitational center. There’s no Kendall Square-kind of place here, no San Francisco–style mega-cluster …

Continue ›››

AI and Cryo-EM: A Powerful Alliance for Unraveling Biological Mysteries

As we advance further into the territories of biotechnology, the convergence of artificial intelligence (AI) and cryo-electron microscopy (Cryo-EM) has emerged as a powerful partnership for unlocking complex biological structures. …

Continue ›››

9 Notable Companies Enabling Decentralized Clinical Trials

Decentralized clinical trials (DCTs) are not a recent invention, but their adoption has accelerated as logistical complexity, geographic dispersion, and patient burden have come under scrutiny. The shift began long …

Continue ›››